Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Anemia

  Free Subscription


Articles published in Int J Hematol

Retrieve available abstracts of 55 articles:
HTML format
Text format



Single Articles


    April 2017
  1. ABAZA Y, Yin CC, Bueso-Ramos CE, Wang SA, et al
    Primary autoimmune myelofibrosis: a case report and review of the literature.
    Int J Hematol. 2017;105:536-539.
    PubMed     Text format     Abstract available


    March 2017
  2. WU L, Mo W, Zhang Y, Zhou M, et al
    Vascular and perivascular niches, but not the osteoblastic niche, are numerically restored following allogeneic hematopoietic stem cell transplantation in patients with aplastic anemia.
    Int J Hematol. 2017 Mar 16. doi: 10.1007/s12185-017-2217.
    PubMed     Text format     Abstract available


  3. IKI S, Ohgi K, Suzuki K
    Eculizumab treatment improved renal hemosiderosis in a patient with paroxysmal nocturnal hemoglobinuria.
    Int J Hematol. 2017;105:231-232.
    PubMed     Text format    


  4. ZAHRAN AM, Saad K, Elsayh KI, Alblihed MA, et al
    Characterization of circulating CD4+ CD8+ double positive and CD4- CD8- double negative T-lymphocyte in children with beta-thalassemia major.
    Int J Hematol. 2017;105:265-271.
    PubMed     Text format     Abstract available


  5. KOMATSU N, Kirito K, Shimoda K, Ishikawa T, et al
    Assessing the safety and efficacy of ruxolitinib in a multicenter, open-label study in Japanese patients with myelofibrosis.
    Int J Hematol. 2017;105:309-317.
    PubMed     Text format     Abstract available


    February 2017
  6. WU L, Xu W, Xu L, Kong Q, et al
    Mitophagy is increased during erythroid differentiation in beta-thalassemia.
    Int J Hematol. 2017;105:162-173.
    PubMed     Text format     Abstract available


    January 2017
  7. HAYAKAWA J, Kanda J, Akahoshi Y, Harada N, et al
    Meta-analysis of treatment with rabbit and horse antithymocyte globulin for aplastic anemia.
    Int J Hematol. 2017 Jan 11. doi: 10.1007/s12185-017-2179.
    PubMed     Text format     Abstract available


  8. IKEBE T, Takata H, Sasaki H, Miyazaki Y, et al
    Hemophagocytic lymphohistiocytosis following influenza vaccination in a patient with aplastic anemia undergoing allogeneic bone marrow stem cell transplantation.
    Int J Hematol. 2017 Jan 4. doi: 10.1007/s12185-016-2177.
    PubMed     Text format    


    December 2016
  9. SEKIGUCHI N, Nishina S, Kawakami T, Sakai H, et al
    Oral cyclophosphamide was effective for Coombs-negative autoimmune hemolytic anemia in CD16+CD56- chronic lymphoproliferative disorder of NK-cells.
    Int J Hematol. 2016 Dec 27. doi: 10.1007/s12185-016-2170.
    PubMed     Text format     Abstract available


    November 2016
  10. ICHIMURA T, Yoshida K, Okuno Y, Yujiri T, et al
    Diagnostic challenge of Diamond-Blackfan anemia in mothers and children by whole-exome sequencing.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  11. NINOMIYA H, Obara N, Chiba S, Usuki K, et al
    Interim analysis of post-marketing surveillance of eculizumab for paroxysmal nocturnal hemoglobinuria in Japan.
    Int J Hematol. 2016;104:548-558.
    PubMed     Text format     Abstract available


    October 2016
  12. GUO Z, Gao HY, Zhang TY, Liu XD, et al
    Analysis of allogeneic hematopoietic stem cell transplantation with high-dose cyclophosphamide-induced immune tolerance for severe aplastic anemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


    August 2016
  13. QI W, Yan L, Liu C, Fu R, et al
    Abnormal histone acetylation of CD8+ T cells in patients with severe aplastic anemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  14. NAKAO S
    Diagnostic problems in acquired bone marrow failure syndromes.
    Int J Hematol. 2016;104:151-2.
    PubMed     Text format    


  15. INOUE S, Kodjebacheva G, Scherrer T, Rice G, et al
    Adherence to hydroxyurea medication by children with sickle cell disease (SCD) using an electronic device: a feasibility study.
    Int J Hematol. 2016;104:200-7.
    PubMed     Text format     Abstract available


  16. FALCHI L, Grillo LM, Diuguid-Gerber JL, Eisenberger AB, et al
    Severe mechanical hemolysis in a patient with thalassemia minor who had undergone inappropriate splenectomy.
    Int J Hematol. 2016;104:147-8.
    PubMed     Text format    


  17. MIYATA T, Uchida Y, Yoshida Y, Kato H, et al
    No association between dysplasminogenemia with p.Ala620Thr mutation and atypical hemolytic uremic syndrome.
    Int J Hematol. 2016;104:223-7.
    PubMed     Text format     Abstract available


  18. MARSH JC, Mufti GJ
    Clinical significance of acquired somatic mutations in aplastic anaemia.
    Int J Hematol. 2016;104:159-67.
    PubMed     Text format     Abstract available


    July 2016
  19. LI Y, He H, Yang L, Li X, et al
    Therapeutic effect of Colla corii asini on improving anemia and hemoglobin compositions in pregnant women with thalassemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  20. CHUNCHARUNEE S, Wong R, Rojnuckarin P, Chang CS, et al
    Efficacy of rabbit antithymocyte globulin as first-line treatment of severe aplastic anemia: an Asian multicenter retrospective study.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  21. FU R, Yan S, Wang X, Wang G, et al
    A monocentric retrospective study comparing pulse cyclophosphamide therapy versus low dose rituximab in the treatment of refractory autoimmune hemolytic anemia in adults.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


    June 2016
  22. TAKAHASHI N, Kameoka J, Takahashi N, Tamai Y, et al
    Causes of macrocytic anemia among 628 patients: mean corpuscular volumes of 114 and 130 fL as critical markers for categorization.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  23. HASHIMOTO K, Harada M, Kamijo Y
    Pure red cell aplasia induced by anti-erythropoietin antibodies, well-controlled with tacrolimus.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  24. SUZUKI T, Kobayashi H, Kawasaki Y, Okazuka K, et al
    Efficacy of combination therapy with anti-thymocyte globulin and cyclosporine A as a first-line treatment in adult patients with aplastic anemia: a comparison of rabbit and horse formulations.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  25. WAN Y, Chen X, An W, Ruan M, et al
    Clinical features, mutations and treatment of 104 patients of Diamond-Blackfan anemia in China: a single-center retrospective study.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  26. BACIGALUPO A, Giammarco S, Sica S
    Bone marrow transplantation versus immunosuppressive therapy in patients with acquired severe aplastic anemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  27. SIWAPONANAN P, Fucharoen S, Sirankapracha P, Winichagoon P, et al
    Elevated levels of miR-210 correlate with anemia in beta-thalassemia/HbE patients.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  28. YU F, Du Y, Han B
    A comparative analysis of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria between Asia and Europe/America.
    Int J Hematol. 2016;103:649-54.
    PubMed     Text format     Abstract available


  29. TANTIWORAWIT A, Charoenkwan P, Hantrakool S, Choeyprasert W, et al
    Iron overload in non-transfusion-dependent thalassemia: association with genotype and clinical risk factors.
    Int J Hematol. 2016;103:643-8.
    PubMed     Text format     Abstract available


  30. PIGATTO PD, Ronchi A, Guzzi G
    Iron overload, G6PD deficiency, and lead levels on blood smears.
    Int J Hematol. 2016;103:724.
    PubMed     Text format    


  31. MIYASAKA N, Miura O, Kawaguchi T, Arima N, et al
    Pregnancy outcomes of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab: a Japanese experience and updated review.
    Int J Hematol. 2016;103:703-12.
    PubMed     Text format     Abstract available


    May 2016
  32. DIAMANTIDIS MD, Neokleous N, Agapidou A, Vetsiou E, et al
    Iron chelation therapy of transfusion-dependent beta-thalassemia during pregnancy in the era of novel drugs: is deferasirox toxic?
    Int J Hematol. 2016;103:537-44.
    PubMed     Text format     Abstract available


    April 2016
  33. SUZUKI K, Muramatsu H, Okuno Y, Narita A, et al
    Immunosuppressive therapy for patients with Down syndrome and idiopathic aplastic anemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  34. NARITA A, Kojima S
    Biomarkers for predicting clinical response to immunosuppressive therapy in aplastic anemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  35. AIZAWA K, Kawasaki R, Tashiro Y, Hirata M, et al
    Epoetin beta pegol, but not recombinant erythropoietin, retains its hematopoietic effect in vivo in the presence of the sialic acid-metabolizing enzyme sialidase.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  36. HASEGAWA D
    The current perspective of low-grade myelodysplastic syndrome in children.
    Int J Hematol. 2016;103:360-4.
    PubMed     Text format     Abstract available


  37. MANABE A
    Guest Editorial: Inherited bone marrow failure and myelodysplasia in children: how much do we know about pediatric diseases?
    Int J Hematol. 2016;103:359.
    PubMed     Text format    


  38. DALLE JH, Peffault de Latour R
    Allogeneic hematopoietic stem cell transplantation for inherited bone marrow failure syndromes.
    Int J Hematol. 2016;103:373-9.
    PubMed     Text format     Abstract available


    March 2016
  39. IMASHUKU S, Muramatsu H, Sugihara T, Okuno Y, et al
    PIEZO1 gene mutation in a Japanese family with hereditary high phosphatidylcholine hemolytic anemia and hemochromatosis-induced diabetes mellitus.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  40. ZHU H, Xu W, Liu H, Wang H, et al
    Expression of activated molecules on CD5B lymphocytes in autoimmune hemolytic anemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  41. HATZIMICHAEL E, Briasoulis E
    Megaloblastic anemia presenting with skin hyperpigmentation.
    Int J Hematol. 2016.
    PubMed     Text format    


  42. FAN X, Kremer Hovinga JA, Shirotani-Ikejima H, Eura Y, et al
    Genetic variations in complement factors in patients with congenital thrombotic thrombocytopenic purpura with renal insufficiency.
    Int J Hematol. 2016;103:283-91.
    PubMed     Text format     Abstract available


    February 2016
  43. MORI T, Koh H, Onishi Y, Kako S, et al
    Impact of cyclophosphamide dose of conditioning on the outcome of allogeneic hematopoietic stem cell transplantation for aplastic anemia from human leukocyte antigen-identical sibling.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  44. KOOK H, Chung NG, Kang HJ, Im HJ, et al
    Acquired aplastic anemia in Korean children: treatment guidelines from the Bone Marrow Failure Committee of the Korean Society of Pediatric Hematology Oncology.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  45. KATSURADA T, Kawabata H, Kawabata D, Kawahara M, et al
    A Japanese family with X-linked sideroblastic anemia affecting females and manifesting as macrocytic anemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


    January 2016
  46. ADDO L, Ikuta K, Tanaka H, Toki Y, et al
    The three isoforms of hepcidin in human serum and their processing determined by liquid chromatography-tandem mass spectrometry (LC-tandem MS).
    Int J Hematol. 2016;103:34-43.
    PubMed     Text format     Abstract available


    November 2015
  47. IKEDA F, Toki T, Kanezaki R, Terui K, et al
    ALDH2 polymorphism in patients with Diamond-Blackfan anemia in Japan.
    Int J Hematol. 2015.
    PubMed     Text format    


    October 2015
  48. WU L, Mo W, Zhang Y, Deng H, et al
    Impairment of hematopoietic stem cell niches in patients with aplastic anemia.
    Int J Hematol. 2015.
    PubMed     Text format     Abstract available


    August 2015
  49. XU ZZ, Zhao BB, Xiong H, Wei BW, et al
    Serum BAFF and APRIL levels in patients with autoimmune hemolytic anemia and their clinical significance.
    Int J Hematol. 2015.
    PubMed     Text format     Abstract available


    July 2015
  50. ONAY H, Aykut A, Karaca E, Durmaz A, et al
    Molecular spectrum of alpha-globin gene mutations in the Aegean region of Turkey: first observation of three alpha-globin gene mutations in the Turkish population.
    Int J Hematol. 2015;102:1-6.
    PubMed     Text format     Abstract available


    June 2015
  51. WANG M, Li X, Shi J, Shao Y, et al
    Outcome of a novel immunosuppressive strategy of cyclosporine, levamisole and danazol for severe aplastic anemia.
    Int J Hematol. 2015.
    PubMed     Text format     Abstract available


    April 2015
  52. YIGIT N, Covey S, Tam W
    Massive splenic hamartoma with bizarre stromal cells.
    Int J Hematol. 2015;101:315-6.
    PubMed     Text format    


  53. SAKURAGI M, Hayashi S, Maruyama M, Kabutomori O, et al
    Clinical significance of IPF% or RP% measurement in distinguishing primary immune thrombocytopenia from aplastic thrombocytopenic disorders.
    Int J Hematol. 2015;101:369-75.
    PubMed     Text format     Abstract available


    February 2015
  54. VANDER MEEREN S, Van Damme A, Jochmans K
    Prominent basophilic stippling and hemochromatosis in glucose-6-phosphate dehydrogenase deficiency.
    Int J Hematol. 2015;101:112-3.
    PubMed     Text format    


  55. UNAL S, Ozdemir O, Ozcimen AA, Oztas Y, et al
    Increase of serum fractalkine and fractalkine gene expression levels in sickle cell disease patients.
    Int J Hematol. 2015;101:114-8.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Anemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: